Skip to content
  • Contacts
  • facebook
  • twitter
  • linkedin
registration | login

News and Events

The official online journal of the International Conference
on Thrombosis and Hemostasis Issues in Cancer
WEBINAR: Insights and challenges in Cardio-Oncology by ICTHIC Editorial Office 17 May 2023
RECORDING AVAILABLE: Challenges in the management of fragile CAT patients (older patient population & palliative care) by ICTHIC Editorial Office 9 March 2023
Abstract submission deadline for ESMO Breast Cancer Congress by ICTHIC Editorial Office 15 February 2023
Abstract submission now open for ESMO 2023 by ICTHIC Editorial Office 15 February 2023
  • Home
  • Thrombosis and cancer
    • Epidemiology
    • Basic Mechanisms
    • Prevention
    • Trials and Therapy
    • Focus on: Atrial fibrillation
    • Focus on: Pediatrics
    • Focus on: COVID-19
  • Guidelines and Tools
  • Congress reports
    • ICTHIC 2022
    • ICTHIC 2021
    • ISTH 2020
    • ASH 2020
    • ASH 2019
    • ISTH 2019
    • ICTHIC 2018
    • ESC 2018
  • News and Events
  • Past webinars
  • About
  • Contacts
  • Editorial Board
  • Most Read
  • Podcast and videos
  • Archive
  • PARTNERSHIP
Webinar

Home › Video › Are new anticoagulants a safe and reasonable alternative to low molecular weight heparins?

Categories ICTHIC 2018, Multimedia, Video

Are new anticoagulants a safe and reasonable alternative to low molecular weight heparins?

Dr. Buller and Dr. Noble comment on their DOACs face-off that took place during the 9th ICTHIC Conference.

Author ICTHIC Editorial OfficeAuthor Simon NoblePosted on 18 May 20183 May 2022 expand the text collaps the text

Post navigation

Previous Previous post: The management of cancer patients with hemostatic disorders (thrombosis and/or bleeding) faces many clinical challenges
Next Next post: Arterial thromboembolism can also be the first clinical manifestation of a neoplasm

ICTHIC magazine is supported by an unrestricted educational grant from

SUBSCRIBE TO OUR NEWSLETTER

I agree to receive updates concerning the content published in ICTHIC MAGAZINE and related promotional content/activities (more details)

ICTHIC magazine is supported by an unrestricted educational grant from

logo polistudium
Scientific and Web contents by Polistudium s.r.l.
Via Anfossi 36, 20135 Milan, Italy
info@polistudium.it
None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor
© COPYRIGHT 2019 ICTHIC Magazine
Privacy policy
None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor.

Accept to continue
By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC Magazine, in order to receive email messages concerning the content published in ICTHIC Magazine and related promotional content/activities. Your email address may also be added to this list as a result of signing up to this Website. Personal Data collected: email address, first name, last name, profession.
ICTHIC CONFERENCE Newsletter By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC, in order to receive newsletters concerning the conference, such as Save the date, information about the meeting venue, the publication of the program, registration fees and deadline, abstract submission deadline and oral communication/poster instructions, hotel booking availability and deadline, social program for accompanying persons, the publication of speakers slides, photo/videogallery of the last edition and information about future editions of the conference. Your email address may also be added to this list as a result of signing up to this Website.